San Clemente, CA, United States of America

John Michael Dobbles

USPTO Granted Patents = 32 

 

Average Co-Inventor Count = 4.5

ph-index = 16

Forward Citations = 1,003(Granted Patents)


Location History:

  • San Diego, CA (US) (2012 - 2021)
  • San Clemente, CA (US) (2014 - 2023)

Company Filing History:


Years Active: 2012-2025

Loading Chart...
Loading Chart...
32 patents (USPTO):Explore Patents

Title: John Michael Dobbles: Innovator in Diabetes Management

Introduction

John Michael Dobbles is a prominent inventor based in San Clemente, California, who has made significant contributions to the field of diabetes management. With a total of 29 patents to his name, Dobbles has dedicated his career to developing innovative medical devices that enhance the lives of individuals living with diabetes.

Latest Patents

Among his latest inventions are two groundbreaking patents:

1. **Integrated Medicament Delivery Device for Use with Continuous Analyte Sensor** - This integrated system is designed for monitoring and treating diabetes. It includes a hand-held medicament injection pen equipped with electronics that interface with a continuous glucose sensor. The device is capable of receiving glucose sensor data, calculating therapy requirements, and automatically setting a bolus dose for user injection, significantly simplifying diabetes management.

2. **Integrated Insulin Delivery System with Continuous Glucose Sensor** - This innovation provides systems and methods for the seamless integration of a continuous glucose sensor, a medicament delivery device, and a controller module. The integration can be manual, semi-automated, or fully automated, representing a significant advancement in automated diabetes care technologies.

Career Highlights

Dobbles has been instrumental in advancing medical technology during his career at Dexcom, Inc., a leading company in diabetes management solutions. His work plays a crucial role in developing devices that enhance patient outcomes through innovative technology.

Collaborations

Throughout his career, Dobbles has collaborated with talented individuals such as Apurv Ullas Kamath and Aarthi Mahalingam. These partnerships have driven the development of new technologies and methodologies that further expand the horizons of diabetes treatment.

Conclusion

John Michael Dobbles exemplifies the spirit of innovation in the healthcare industry. His extensive patent portfolio and commitment to improving diabetes management through technology make him a valuable asset to the medical field. As he continues to innovate at Dexcom, Inc., the impact of his work promises to create a lasting legacy for those living with diabetes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…